{"product_id":"intensive-review-of-nephrology-2019","title":"Intensive Review of Nephrology 2019","description":"\u003ch2\u003eIntensive Review of Nephrology 2019 ( Videos)\u003c\/h2\u003e\u003cbr\u003eThe Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e(ACCME) to provide continuing medical education for physicians.The Harvard Medical School designates\u003c\/li\u003e\n\u003cli\u003ethis enduring material for a maximum of 46.50 AMA PRA Category 1 Credits ™. Physicians should claim\u003c\/li\u003e\n\u003cli\u003eonly the credit commensurate with the extent of their participation in the activity.\u003c\/li\u003e\n\u003cli\u003eDate of Original Release: October 1, 2019\u003c\/li\u003e\n\u003cli\u003eTermination Date: January 31, 2022 (Please note that AMA PRA Category 1 Credits ™ will no longer be\u003c\/li\u003e\n\u003cli\u003eissued for the activity after this date)\u003c\/li\u003e\n\u003cli\u003eEstimated Time to Complete the Activity: 46.50 hours\u003c\/li\u003e\n\u003cli\u003e credit is awarded upon successful completion of a course evaluation and post-test.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eABIM Medical Knowledge MOC Points\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eIntensive Review of Nephrology 2019 ( Videos) Successful completion of this  activity, which includes\u003c\/li\u003e\n\u003cli\u003eparticipation in the evaluation component, enables the participant to earn up to 46.50 Medical Knowledge\u003c\/li\u003e\n\u003cli\u003eMOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC)\u003c\/li\u003e\n\u003cli\u003eprogram. Participants will earn MOC points equivalent to the amount of credits claimed for the activity. It is\u003c\/li\u003e\n\u003cli\u003ethe  activity provider’s responsibility to submit participant completion information to ACCME for the\u003c\/li\u003e\n\u003cli\u003epurpose of granting ABIM MOC points.\u003c\/li\u003e\n\u003cli\u003eOn the course evaluation page please indicate “Yes” when asked if you would like to receive ABIM MOC points for your participation in this enduring activity. You will then be required to provide your ABIM\u003c\/li\u003e\n\u003cli\u003eID # and your Date of Birth. Points earned will equal the amount of AMA PRA Category 1 Credits ™ claimed.\u003c\/li\u003e\n\u003cli\u003eHMS will upload the participant data, including the points earned, directly to the ABIM so that it will\u003c\/li\u003e\n\u003cli\u003eappear on the ABIM diplomates transcript. These points will not appear on your certificate provided at the\u003c\/li\u003e\n\u003cli\u003eend of this enduring activity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDisclosure Policy\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eHarvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors,\u003c\/li\u003e\n\u003cli\u003ereviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be\u003c\/li\u003e\n\u003cli\u003eprovided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and\u003c\/li\u003e\n\u003cli\u003eunlabeled or investigational uses of products during their presentations.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eDisclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.\u003cbr\u003e\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\u003cbr\u003eAfter viewing this program, participants will be better able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eSummarize current\/recommended nephrology guidelines in clinical practice\u003c\/li\u003e\n\u003cli\u003eExplain the differential diagnosis of complex clinical presentations of patients with renal disorders\u003c\/li\u003e\n\u003cli\u003eIdentify\/integrate current therapeutic options for specific renal disorders\u003c\/li\u003e\n\u003cli\u003eReview and interpret up-to-date literature relevant to clinical practice\u003c\/li\u003e\n\u003cli\u003eDescribe pathophysiological mechanisms as they apply to management of renal disease\u003c\/li\u003e\n\u003cli\u003eApply learning objectives to the ABIM Nephrology certification\/recertification examinations\u003c\/li\u003e\n\u003cli\u003eACGME Competencies\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eThis course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003ePatient Care and Procedural Skills\u003c\/li\u003e\n\u003cli\u003eMedical Knowledge\u003c\/li\u003e\n\u003cli\u003ePractice-Based Learning and Improvement\u003c\/li\u003e\n\u003cli\u003eTarget Audience\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003eThe target audience for the Intensive Review of Nephrology Course is clinical and academic nephrologists, internists, pediatricians, and primary care physicians\/trainees preparing for ABIM nephrology certification\/recertification examinations and\/or seeking a comprehensive update in renal medicine and its subspecialties.\u003cbr\u003e\u003ch3\u003eTopics\/Speaker:\u003c\/h3\u003e\n\u003ch3\u003eGlomerulonephritis\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eRenal Physiology for the Boards – Melanie P. Hoenig, MD\u003c\/li\u003e\n\u003cli\u003eBasic Concepts of Immunology in Autoimmune Kidney Disease – Ramon G. Bonegio, MD\u003c\/li\u003e\n\u003cli\u003eRenal Pathology in 2019: Part 1 – Helmut G. Rennke, MD\u003c\/li\u003e\n\u003cli\u003eRenal Pathology in 2019: Part 2 – Helmut G. Rennke, MD\u003c\/li\u003e\n\u003cli\u003eCurrent Approaches to Urine Sediment Analysis – Martina M. McGrath, MB BCh\u003c\/li\u003e\n\u003cli\u003eChallenging Pathology Cases – Helmut G. Rennke, MD\u003c\/li\u003e\n\u003cli\u003eIgA Nephropathy – Gerald B. Appel, MD\u003c\/li\u003e\n\u003cli\u003eMembranous Nephropathy – Laurence H. Beck, Jr., MD, PhD\u003c\/li\u003e\n\u003cli\u003eRapidly Progressive Glomerulonephritis – John L. Niles, MD\u003c\/li\u003e\n\u003cli\u003eUpdate on Lupus Nephritis – Gerald B. Appel, MD\u003c\/li\u003e\n\u003cli\u003eGlomerulonephritis: Questions \u0026amp; Answers Session – Gerald B. Appel, MD\u003c\/li\u003e\n\u003cli\u003eMetabolic Management of Kidney Stones – Gary C. Curhan, MD, ScD\u003c\/li\u003e\n\u003cli\u003eAnemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA\u003c\/li\u003e\n\u003cli\u003eMust-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eElectrolytes and Acid Base\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eWorkshop: Hyponatremia and Hypernatremia – David B. Mount, MD\u003c\/li\u003e\n\u003cli\u003eElectrolyte and Acid Base Disorders – Questions \u0026amp; Answers Session – Part 1 – Alan S.L. Yu, MB, BChir\u003c\/li\u003e\n\u003cli\u003eHypokalemia and Hyperkalemia – David B. Mount, MD\u003c\/li\u003e\n\u003cli\u003eAcidosis – Alan S.L. Yu, MB, BChir\u003c\/li\u003e\n\u003cli\u003eAlkalosis – Alan S.L. Yu, MB, BChir\u003c\/li\u003e\n\u003cli\u003eCases from Renal Grand Rounds at The Brigham – David B. Mount, MD\u003c\/li\u003e\n\u003cli\u003eElectrolyte and Acid Base Disorders – Questions \u0026amp; Answers Session – Part 2 – Alan S.L. Yu, MB, BChir\u003c\/li\u003e\n\u003cli\u003eGenetics and Kidney Disease – Friedhelm Hildebrandt, MD\u003c\/li\u003e\n\u003cli\u003eUpdate on Polycystic Kidney Disease – Ronald D. Perrone, MD\u003c\/li\u003e\n\u003cli\u003ePediatric Nephrology – Michael J.G. Somers, MD\u003c\/li\u003e\n\u003cli\u003ePregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH\u003c\/li\u003e\n\u003cli\u003eGeriatric Nephrology – Ernest I. Mandel, MD\u003c\/li\u003e\n\u003cli\u003eNephrology Board Review Practice 1 – Finnian R. McCausland, MB BCh, MMSc, FRCPI\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eCKD and General Nephrology\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eUpdate on Renovascular Disease – Joseph M. Garasic, MD\u003c\/li\u003e\n\u003cli\u003eManagement of Hypertension after SPRINT – Richard J. Glassock, MD\u003c\/li\u003e\n\u003cli\u003eSecondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc\u003c\/li\u003e\n\u003cli\u003eCardiovascular Disease and Renal Disease – Finnian R. McCausland, MB BCh, MMSc, FRCPI\u003c\/li\u003e\n\u003cli\u003eLiver and the Kidney – Andrew S. Allegretti, MD, MSc\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eAcute Kidney Injury\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD\u003c\/li\u003e\n\u003cli\u003eAcute Kidney Injury Syndromes – Alice Sheridan, MD\u003c\/li\u003e\n\u003cli\u003eCancer and Acute Kidney Injury – Albert Q. Lam, MD\u003c\/li\u003e\n\u003cli\u003eParaprotein Induced Kidney Injury – Albert Q. Lam, MD\u003c\/li\u003e\n\u003cli\u003eClinicopathological Conference – Richard J. Glassock, MD, Joel M. Henderson, MD, PhD, and Martina M. McGrath, MB BCh\u003c\/li\u003e\n\u003cli\u003eFSGS: A Lesion, Not a Disease – Richard J. Glassock, MD\u003c\/li\u003e\n\u003cli\u003eNephrology Board Review Practice 2 – Mallika Mendu, MD, MBA\u003c\/li\u003e\n\u003cli\u003eICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh\u003c\/li\u003e\n\u003cli\u003eInterstitial Nephritis: Overview for the Boards – Julie M. Paik, MD, ScD, MPH\u003c\/li\u003e\n\u003cli\u003eHow to Pass the Boards – David E. Leaf, MD, MMSc\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eTransplantation\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eWhy Do We Reject a Transplant? – Jamil R. Azzi, MD\u003c\/li\u003e\n\u003cli\u003eTransplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP\u003c\/li\u003e\n\u003cli\u003eImmunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD\u003c\/li\u003e\n\u003cli\u003eEarly Post-Transplant Management – Anil K. Chandraker, MD\u003c\/li\u003e\n\u003cli\u003ePoisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD\u003c\/li\u003e\n\u003cli\u003eLate Loss of the Kidney Transplant – Andrew M. Siedlecki, MD\u003c\/li\u003e\n\u003cli\u003eInfections in Transplant Recipients – Sarah P. Hammond, MD\u003c\/li\u003e\n\u003cli\u003eTransplant Cases: Board Review Practice – Melissa Y. Yeung, MD and Edgar L. Milford, Jr., MD\u003c\/li\u003e\n\u003cli\u003ePre-Transplant Evaluation of Recipients – Jamil R. Azzi, MD, and Sayeed Malek, MD, FACS\u003c\/li\u003e\n\u003cli\u003eDonor Evaluation – Kassem Safa, MD\u003c\/li\u003e\n\u003cli\u003eThrombotic Microangiopathies – Jean M. Francis, MD\u003c\/li\u003e\n\u003cli\u003eLate Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD\u003c\/li\u003e\n\u003cli\u003eTransplant Board Review – Leonardo V. Riella, MD, PhD\u003c\/li\u003e\n\u003cli\u003eMust Know Board Zebras – Emily S. Robinson, MD, MPH\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDialysis\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eDialysis Dosing – J. Kevin Tucker, MD\u003c\/li\u003e\n\u003cli\u003eMineral and Bone Disease – David Bushinsky, MD\u003c\/li\u003e\n\u003cli\u003eDialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD\u003c\/li\u003e\n\u003cli\u003ePearls in Mineral and Bone Disease – David Bushinsky, MD\u003c\/li\u003e\n\u003cli\u003eChronic Kidney Disease Epidemiology: A 2019 Update – Gearoid M. McMahon, MB BCh\u003c\/li\u003e\n\u003cli\u003ePeritoneal Dialysis – Joanne M. Bargman, MD, FRCPC\u003c\/li\u003e\n\u003cli\u003ePeritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC\u003c\/li\u003e\n\u003cli\u003eRenal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD\u003c\/li\u003e\n\u003cli\u003eDialysis Vascular Access: Assessment and Complications – Dirk M. Hentschel, MD\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954307666018,"sku":"MED-AMB00888","price":15.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/image_efdfc2f6-eb18-4bff-810f-f9be25e05aa2.jpg?v=1779370806","url":"https:\/\/meducourse.com\/products\/intensive-review-of-nephrology-2019","provider":"Meducourse","version":"1.0","type":"link"}